Syphilis: What tests are used and how to take them

Syphilis is a systemic infection caused by Treponema pallidum. The disease is divided into stages based on clinical manifestations: primary, secondary, latent, and latent. Neurosyphilis, ocular syphilis, and ear syphilis are also considered separately. The stage determines not only the symptoms but also the tactics of laboratory diagnosis, treatment, and follow-up. [1]

In modern medicine, the term "syphilis test" refers not to a single test, but to a diagnostic process. It is based on two groups of serological tests: non-treponemal tests, which detect antibodies to lipid antigens, and treponemal tests, which detect antibodies to T. pallidum itself. For a correct diagnosis, both groups are almost always needed. [2]

Non-treponemal tests are more often used to assess the activity of the disease and for post-treatment monitoring. Their results are expressed in titers, and the doctor uses the titer change to determine whether there is significant improvement, continued activity, or possible reinfection. Treponemal tests are used to confirm infection, but are much less suitable for monitoring therapy. [3]

The situation is further complicated by the fact that laboratories may use two different screening protocols. In the "traditional" algorithm, a non-treponemal test is performed first, followed by a treponemal test to confirm a positive result. In the "reverse" algorithm, an automated treponemal test is performed first, followed by a quantitative non-treponemal test, and if there is a discrepancy, another treponemal test of a different type is required. [4]

Therefore, the modern answer to the question "which test should I take for syphilis" is: it's not "the one best test," but rather the combination that best suits the specific clinical situation. The testing routes will vary for suspected early chancre, asymptomatic screening, pregnancy, post-treatment, and suspected neurosyphilis. [5]

Table 1. Main types of tests for syphilis.

Test type	What does it reveal?	What is it for?	The main limitation
Non-treponemal test	Antibodies to lipid antigens	Screening according to the traditional algorithm, quantitative control after treatment	May be negative in very early syphilis and give false positive results
Treponemal test	Antibodies to T. pallidum	Confirmation of infection, screening using the reverse algorithm	Often remains positive after treatment
Direct examination from the ulcer	The pathogen itself or its nucleic acid	Early primary syphilis, when the blood may still be negative	Not available everywhere
Cerebrospinal fluid analysis	Non-treponemal and treponemal markers, cellularity, protein	Suspected neurosyphilis	Not used routinely in asymptomatic patients
Home or rapid antibody test	Screening antibodies	A quick first step	Does not confirm the diagnosis definitively

Source for the table. [6]

What tests are used most often?

Classic nontreponemal tests include the rapid plasma reagin (RPR) and the sexually transmitted disease laboratory (STD) test. Their advantage is that they provide a quantitative titer rather than simply a "positive" or "negative" response. This is why they remain key for post-treatment monitoring. CDC 2024 specifically recommends defining and clearly reporting the endpoint titer, rather than reporting vague values with mathematical symbols. [7]

Treponemal tests include enzyme-linked immunosorbent assays, chemiluminescence assays, and other antibody-based methods, as well as confirmatory tests such as Treponema pallidum particle agglutination tests. They are particularly important in the reverse algorithm, where the laboratory first performs automated treponemal screening. However, these tests are not suitable for monitoring treatment response because they remain reactive for a very long time in most patients. [8]

In early syphilis, especially when a chancre is present but the blood is still negative, direct methods come into play. The CDC emphasizes that darkfield microscopy and molecular methods from exudate or lesional tissue are the definitive methods for diagnosing early syphilis. However, darkfield microscopy is not recommended for mouth ulcers due to the risk of confusing the syphilis pathogen with common oral spirochetes. [9]

Direct tests are especially valuable because serology can be delayed. CDC 2024 notes that both treponemal and nontreponemal tests are not yet reactive in some patients with primary syphilis, especially if the ulcer is recent. At the same time, direct tests from the ulcer can provide an earlier response and eliminate the need to wait for seroconversion. [10]

Finally, it's worth mentioning the rapid and at-home tests separately. Rapid treponemal tests from capillary blood are useful for outreach work and where a quick initial decision is needed, but a positive result must be confirmed by laboratory testing. In August 2024, the FDA approved the first at-home syphilis antibody test, which detects possible current or past infection in 15 minutes, but is not sufficient for diagnosis on its own and should not be used to initiate or stop treatment. [11]

Table 2. What is best suited in different clinical situations.

Situation	Preferred laboratory emphasis
Routine asymptomatic screening	Serological algorithm
Recent chancre	Serology plus direct ulcer examination
Post-treatment follow-up	Quantitative nontreponemal test
Questionable treponemal screening	Second treponemal test of a different type
Home self-test	Only screening start, then confirmation
Suspected neurosyphilis	Serum serology plus cerebrospinal fluid examination as indicated

Source for the table. [12]

How to take the test and when it becomes informative

For routine serological blood testing, no special preparation is usually required. MedlinePlus notes that rapid plasma reagin and classical treponemal antibody tests generally require no special preparation. In practice, it is more important to accurately report the date of possible exposure, symptoms, presence of an ulcer, and previous treatment for syphilis than to fast. [13]

The most common patient error is donating blood too soon after exposure to the risk of infection and misinterpreting a negative result as definitive. BASHH 2024 states that negative serological results within 3 months of infection do not completely rule out early syphilis, and treponemal screening tests can be negative even before the appearance of the chancre and up to 2 weeks after its onset. [14]

If a suspicious ulcer is already present and the blood is negative, the current approach is not to simply "rest easy." The 2024 British guidelines recommend repeating serology 2 weeks after the identification of a possible chancre if direct tests from the ulcer are negative and clinical suspicion remains. The 2024 CDC also emphasizes that early primary syphilis can be seronegative. [15]

For asymptomatic patients after high-risk exposure, the logic is also cautious. BASHH recommends repeat screening three months after high-risk exposure, as an earlier negative result does not rule out early infection. This is especially important for people with ongoing risk, repeated exposures, and high epidemiological background. [16]

Finally, to ensure post-treatment follow-up, blood samples should be collected as closely as possible. The CDC recommends comparing results from the same non-treponemal test, preferably from the same laboratory or at least the same manufacturer. Otherwise, method variability may mimic clinical deterioration or, conversely, obscure it. [17]

Table 3. Practical reminder on deadlines and re-tests.

Situation	What is important to remember
Blood immediately after the risk	It may still be negative.
There is a fresh chancre, serology is negative.	Direct ulcer testing and repeat serology are needed.
Suspicious ulcer, direct test negative	Serology is repeated after approximately 2 weeks.
High-risk contact without symptoms	Repeat screening is appropriate after 3 months
Post-treatment follow-up	Titers are compared using the same non-treponemal method.

Source for the table. [18]

How to read results: traditional and reverse algorithms

In the traditional algorithm, a non-treponemal test is performed first. If it's positive, the laboratory or physician must confirm the result with a treponemal test. This approach is common, works well for screening, and is especially convenient where immediate quantitative titer is important. However, its weakness is lower sensitivity in very early primary syphilis and in some late cases. [19]

In the reverse algorithm, an automated treponemal test is performed first. If it is positive, the next step is a quantitative non-treponemal titer test. If this is also positive, the situation most often corresponds to current or previously treated syphilis, and further management depends on the patient's medical history and stage. [20]

If the first treponemal test is positive and the non-treponemal test is negative, this is not a reason to immediately declare the result false or true. The CDC recommends in such cases performing a second treponemal test, different from the first, preferably based on different antigens. It is this third step that resolves most "strange" serological situations. [21]

If the second treponemal test is also positive, and the patient has a history of adequate treatment and no signs of new risk, additional treatment is usually not necessary. However, if there was a possible recent reinfection, the CDC recommends repeating the nontreponemal test 2-4 weeks after examination and history taking to avoid missing very early reinfection. [22]

If the second treponemal test is negative and the clinical probability of syphilis is low, further testing and treatment are usually unnecessary. This situation most often reflects a false-positive initial treponemal screening, especially in groups with low infection prevalence. This is precisely why a second treponemal test of a different type is needed. [23]

Table 4. Traditional algorithm.

Step	Result	What to do next
Non-treponemal test	Negative	At low suspicion, syphilis is unlikely
Non-treponemal test	Positive	Confirm with a treponemal test
Treponemal test after positive non-treponemal	Positive	Syphilis is probable, further staging and treatment based on the anamnesis
Treponemal test after positive non-treponemal	Negative	Think about a false-positive non-treponemal test, evaluate the clinical picture and risk

Source for the table. [24]

Table 5. Reverse algorithm.

Step	Result	What to do next
First treponemal test	Negative	At low suspicion, syphilis is unlikely
First treponemal test	Positive	Perform a quantitative nontreponemal test
Treponemal positive, non-treponemal positive	Consistent with current or previously treated syphilis	Staging, assess history and treat as needed
Treponemal positive, non-treponemal negative	A second treponemal test of a different type is needed	This step is mandatory.
First treponemal positive, non-treponemal negative, second treponemal positive	Either previously treated syphilis, or untreated, or very early infection	Assess the anamnesis, risk, if necessary, repeat the non-treponemal test in 2-4 weeks
First treponemal positive, non-treponemal negative, second treponemal negative	At low risk, false positive screening is more common	Usually no treatment is required

Source for the table. [25]

What do titers mean and how is the patient monitored after treatment?

For nontreponemal tests, it's not just reactivity that matters, but the titer itself. The CDC emphasizes that a fourfold change in titer, or a change of two dilutions, is considered clinically significant. For example, a change from 1:32 to 1:8 or from 1:8 to 1:32 is considered significant, while smaller fluctuations may simply be laboratory variability. [26]

After treatment, nontreponemal test titers typically decline and may eventually become negative, but this does not happen in all patients. In some patients, titers decrease by less than a quarter, while in others, they decline adequately but then persist at a low level for a long time. This condition is sometimes called serologic fixation, or "serofast." This phenomenon alone does not equate to treatment failure unless there are new symptoms, a new risk, or a rebound in titers. [27]

Treponemal tests are rarely used for post-therapy monitoring. The CDC notes that in most patients, they remain reactive for life, although in 15-25% of people treated in the primary stage, they may become negative after 2-3 years. However, in routine monitoring, non-treponemal titers, rather than these, should be used as a guide. [28]

A repeated increase in titer is particularly important for suspecting reinfection. BASHH indicates that a fourfold increase in titer compared to an earlier sample suggests recent new syphilis. Therefore, high-quality monitoring requires a starting titer on the day of treatment initiation and subsequent checkpoints. [29]

It is crucial not to attempt to stage the disease based solely on numbers. BASHH explicitly warns that serology should not be used alone for accurate staging, determining the duration of therapy, or diagnosing reinfection without taking into account the clinical presentation and treatment history. The same serological profile can be found at different stages, especially if the disease is old or has already been treated. [30]

Table 6. How to read titers after treatment.

Serological situation	What does it most often mean?
The titer decreased by 4 times or more	Usually good serological response
The titer decreased, but less than 4 times	Insufficient response is possible, clinical analysis is needed
The titer decreased and then remained steadily low.	Serofast without active disease is possible
The titer increased 4 times or more	Thinking about reinfection or treatment failure
The treponemal test remains positive.	Typically expected and not used to assess cure

Source for the table. [31]

Special situations: pregnancy, neurosyphilis, rapid tests

During pregnancy, screening for syphilis should be early and universal. In 2025, the USPSTF reaffirmed that early universal serologic screening during pregnancy significantly reduces the risk of congenital syphilis and associated adverse outcomes. If a woman is not screened early, testing should be performed as soon as possible. [32]

If syphilis is diagnosed during pregnancy and treatment is administered before 24 weeks, the CDC recommends not repeating titers until at least 8 weeks after treatment and then checking them at delivery. If diagnosis and treatment occur after 24 weeks, titers should be checked at delivery. Penicillin remains the only proven effective treatment for pregnant women, and allergies require desensitization and penicillin therapy. [33]

Neurosyphilis is diagnosed differently than typical latent or early syphilis. The CDC emphasizes that no single cerebrospinal fluid test is a universal gold standard. Diagnosis is based on a combination of neurological, ocular, or auditory symptoms, reactive serum serology, and cerebrospinal fluid (CSF) analysis. A CSF STD laboratory test is highly specific, but its sensitivity is limited. [34]

Routine lumbar puncture is not necessary for all patients with positive serology. Both the CDC and BASHH believe that cerebrospinal fluid testing is indicated primarily for clinical signs of neurological involvement, not simply for asymptomatic syphilis. This is important because in asymptomatic patients, cerebrospinal fluid changes may be nonspecific and not change management. [35]

Rapid and home tests can be used as a first step, but not as a final solution. The FDA emphasizes that a home syphilis antibody test can provide results in approximately 15 minutes and can indicate current or past infection, but further laboratory testing is required to confirm the diagnosis. Furthermore, if you have had recent exposure, you should seek medical attention regardless of the results of a home test. [36]

FAQ

Is it possible to get a single test to know for sure if you have syphilis?
Usually, no. Modern diagnostics almost always require a combination of non-treponemal and treponemal tests, and in the case of early chancre, a direct examination of the ulcer may be necessary. [37]

Which test is more important after treatment—treponemal or nontreponemal?
For post-therapy monitoring, a nontreponemal titer test is more important. Treponemal tests often remain positive for a long time and are generally not suitable for assessing cure. [38]

If a treponemal test is positive, does it always indicate active syphilis?
No. It can remain positive after a previous and cured case of syphilis. Therefore, it is necessary to review the medical history, non-treponemal titer, and, if necessary, a second treponemal test of a different type. [39]

If the blood is negative, is syphilis definitely not present?
Not always. In very early primary syphilis, especially with fresh chancre, serology may still be negative. In such cases, direct methods from the ulcer and repeat serology after a short interval are helpful. [40]

Should I take the test on an empty stomach?
Usually not. Routine serological tests for syphilis generally do not require any special preparation. [41]

What does a "titer of 1:32" or "1:8" mean?
This is a quantitative indicator of a non-treponemal test. A clinically significant change typically requires a fourfold shift, that is, a change of 2 dilutions. [42]

How soon after a risk assessment should a repeat blood test be performed if the initial result is negative?
In cases of high risk and asymptomatic individuals, BASHH recommends repeat screening after 3 months. If a suspicious chancre is present and the initial serology is negative, a repeat test is often performed after approximately 2 weeks. [43]

Is there a home test for syphilis yet?
Yes. The FDA approved the first over-the-counter home test for syphilis antibodies in 2024. However, it is only suitable for initial screening and does not replace confirmatory laboratory testing. [44]

Should all pregnant women be tested for syphilis?
Yes, early universal screening during pregnancy is recommended. It is one of the most important ways to prevent congenital syphilis. [45]

When is a cerebrospinal fluid analysis needed?
Not for everyone. It is primarily needed if neurosyphilis, ocular syphilis, or aural syphilis are suspected and is evaluated only in conjunction with symptoms and serum serology. [46]